Documentation scienceplus.abes.fr version Bêta

À propos de : A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria        

AttributsValeurs
type
Is Part Of
Subject
Title
  • A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria
has manifestation of work
related by
Author
Abstract
  • Abstract. 31 pairs of patients with complicated falciparum malaria (with anaemia, jaundice, raised blood urea, hyperpyrexia or more than 2% of erythrocytes parasitized) were treated with artemether or quinine. All patients in the artemether group survived but 2 of those treated with quinine died. Fever clearance time and parasite clearance time of patients treated with artemether were significantly shorter than in the quinine-treated group. One patient who failed to respond to quinine within 72 h was saved with artemether. Follow-up of the patients showed that 9 of 23 (39.1%) recrudesced on day 28 in the artemether group. In the quinine group the recrudescence rate was 9% (2 of 22). Hence artemether may be considered as one of the drugs of choice for severely ill patients; it may even be better than quinine.
article type
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata